Anavex Life Sciences Corp (AVXL)

[Huggy2]

From the Yahoo board -
FDA Adviser Said To Quit Over Approval Of Biogen's Alzheimer's Drug His Expert Panel Doubted

01:07 PM EDT, 06/09/2021 (MT Newswires) -- A member of the US Food and Drug Administration's expert panel for nervous system therapies stepped down from his post Monday following the regulator's approval of Biogen's (BIIB) Alzheimer's therapy Aduhelm, Stat News reported Tuesday.
Joel Perlmutter, a member of the advisory committee that recommended against approval of the drug, told Stat in an email that his resignation was "due to this ruling by the FDA without further discussion with our advisory committee," according to the medical news site.
In the November 2020 advisory voting, 10 of 11 FDA panelists found there was not enough evidence that Aduhelm is effective in slowing cognitive decline caused by Alzheimer's while one voted "uncertain," according to the report. However, the FDA still approved the treatment Monday.
While the FDA is not required to follow its advisory committees' recommendations, in the past "overrulings generally came when the votes were closer," Stat News said.